George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
I am watching this link a week now. For some reason only a few to none companies are successful and start their trails.
Nowadays even MHRA may lack on professionals, who knows.
https://ichgcp.net/de/news
Cheers, cucio.
I am not that much familiar with the rules but may have read about 10% in connection with mid cap companies. Looks like up to 100% then is allowed yet suggestion depends on the current status and shape the company is in.
Am I right in saying this is all about a review or seeking advice of MHRA if non-clinical data?
MHRA only yet notified that it has not been able to approve CTA.
Can also mean the CRO involved no longer exists or didn't pay its commercial fees or taxes in time or similiar.
Do we wish for a 200% rise, too? Best todays story is Merrimack
https://investors.merrimack.com/news-releases/news-release-details/merrimack-provides-ipsen-report-onivyder-regimen-demonstrated
https://investors.merrimack.com/news-releases/news-release-details/merrimack-provides-ipsen-report-onivyder-regimen-demonstrated
Here we go. Best estimate of costs probably based on wrong consumptions?
Think of 10% inflation in 2022 alone.
Goldman forecasts UK inflation to hit 22.4% in 2023
Bank says even if energy costs moderate, inflation could still peak at 14.8% in January
https://www.zawya.com/en/world/uk-and-europe/goldman-forecasts-uk-inflation-to-hit-224-in-2023-rsc55w0l
In my opinion even considering further expenditure re commercialization for all the compounds or SRA737 in particular makes sense to claim in one go. I like this idea of a strategy SOG brought up earlier on.
Me thinks BiG Pharma simply try hard to licence precious molecules or compounds from a minor or selfmade Business Partner. No expert though.
Could this be us?
https://rewardingresearch.co.uk/current-studies/
Plan B
I wonder if CTA now is on the cards. Was a capital injection then helpful and acceptable? With all respect, LTHs are in cheap enough and happy to support the prospective CTA like all other down the line. Any comments?